Protein production startup

Synthetic RNA controls are ideal for reaction control, no risk of contamination NB1 (biosafety level 1) and monitor all steps of your PCR. They are fragments of the genetic regions of the viral RNA SARS-CoV-2. Routinely used and synthesized using cell-free technology, viral RNA fragments are delivered at concentrations of ng, ug and mg for use and standardization of your PCR reaction in routine or clinical research.

SARS-CoV-2 Positive RNA Control Gene N

SARS-CoV-2 Positive RNA Control ORFB3

SARS-CoV-2 Positive RNA Control ORFA1

SARS-COV-2 CONTROLS PROMOTION

RNA controls for SARS-VOC-2 (COVID-19) with up to 20%OFF (for a limited time)

Talk to one of our consultants

WhatsApp: +55 11 3039 8362
E-mail: yourfriends@biolinker.tech

Our Cell-Free Protein Synthesis Kit (CFPS) is ideal for protein development in your shape lab. until 100 times faster that traditional methodologies (allowing protein synthesis in less than 24h).

With our kit it is possible to achieve yield up to 0.5mg/ml, including the synthesis of proteins with a high level of toxicity.

Developed from E.Coli extract

HIGH QUALITY and RELIABILITY in its protein synthesis.

Talk to one of our consultants

WhatsApp: +55 11 3039 8362
E-mail: yourfriends@biolinker.tech

At BioLinker we use proprietary methodologies for discovery, development and synthesis of peptides and proteins

DISCOVERY AND ACCELERATED DEVELOPMENT OF PROTEINS (DDAP)

to identify and develop target proteins and peptides

ACCELERATED DISCOVERY

With DDAP it is possible to accelerate the discovery of new molecules and ligands for use in research, processes or with therapeutic potential

INCREASE EFFICIENCY

With DDAP it is possible to increase the efficiency in the selection of molecules and ligands of interest, enabling greater specificity in a reduced time

HIGH PERFORMANCE SCREENING

With DDAP it is possible to perform a high-performance screening from the molecules found after the discovery process

ACCELERATED DEVELOPMENT

With DDAP it is possible to accelerate the development of new epitopes and molecules, from discovery to purification, in a few months instead of years

LOWEST COST

With DDAP the biomolecule development process is optimized, reducing the occurrence of procedural failures and study time, thus having a lower operating cost

For the development of DDAP we use three key technologies:

• Cell-Free Protein Synthesis (Cell-Free);
• Phage Display;
• Ribosomes Display.

BioLinker is ONE AMONG 4 only companies using Cell-Free technologies, Phage Display and Ribosomal Display.

Talk to one of our consultants

WhatsApp: +55 11 3039 8362
E-mail: yourfriends@biolinker.tech

DETERMINATION OF ASSOCIATION CONSTANT PROTEIN/TARGET

BioLinker in partnership with NANOTEMPER-BR is with 3 entire months providing protein interaction analysis services. very simple and easy, the service uses Nanotemper equipment to determine the protein-protein and protein-DNA dissociation constants, virus-protein. The values ​​and deadlines are unmissable!

DETERMINATION OF INFLATION TEMPERATURE PROTEIN/BATCH MELTING TEMPERATURE

BioLinker in partnership with NANOTEMPER-BR is with 3 entire months providing analysis services to assess protein stability In different buffers or in different conditioning to determine batch validity and shelf life. very simple and easy, the service uses Nanotemper equipment to determine the bending temperature and melting temperature, inferring protein stability after processing or shelf life and packaging. The values ​​and deadlines are unmissable!

Talk to one of our consultants

WhatsApp: +55 11 3039 8362
E-mail: yourfriends@biolinker.tech